期刊文献+

Relationship between interleukin-18 levels and characterization of atherosclerotic plaque and percutaneous coronary intervention

下载PDF
导出
摘要 Background lnterleuldn-18(IL-18)plays a key role in the development,progression and outcome of coronary artery disease and its complications.However,its variability relation to the characterization of atherosclerotic plaque and percutaneous coronary intervention are still unknown.Methods Fifty four patients with coronary artery disease[22 patients with stable angina(SA)and 32 patients with acute coronary syndrome(ACS)]were enrolled in this study.All patients underwent percutaneous coronary intervention(PCI).The stability of the plaques at the criminal vessels was assessed with analogical IVUS.Serum IL-18 levels were measured at the time points of 5 rain before PCI,and Oh,6h,24h and lmonth after PCI in all patients.Results ACS group consisted mainly of lipidic unstable plaques while SA group of fibrous stable plaques.Moreover,compared with those in SA group,eccentricity index(EI)and remodeling index(RI)were significantly higher in ACS group.Positive remodeling was seen in ACS group while negative or no remodeling in SA group.Further,serum IL-18 levels were significantly elevated in patients with ACS than those in SA group before PCI,increased at Oh,6h,24h after PCI(P<0.05)and were not significant different at 1 month after PCI from those before PCI.Conclusions There is significant difference in the composition and structural characteristics of atherosclerotic plaques between ACS and UA groups.PCI triggersd and enhances the inflammatory response in a short time.Serum levels of IL-18 are the predictors of progression of unstable plaque in atherosclerosis.Post-operative complications of PCI might be reduced by inhibiting IL-18.
出处 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2008年第1期21-24,共4页 老年心脏病学杂志(英文版)
  • 相关文献

参考文献14

  • 1[1]Mallat Z,Corbaz A,Scoazec A,Besnard S,Leseche G,Chavatchko Y,et al.Expression of interleukin-18 in human atherosclerotie plaques and relation to plaque instability.Circulation 2001;104:598-603.
  • 2[2]Okamura H,Tsutsui H,Kashiwamura S,et al.lnterleukin-18:a novel cytokine that augments both innate and acquired immunity.Adv Immunol 1998,70:281-312.
  • 3[3]Dinarello CA.interleukin-18,a proinflammatory cytokine.Eur Cytokine Net 2000;11:483-6.
  • 4[4]Lee KWJ,Hill JS.,Walley KR,Frohliclmd JJ..Relative value of multiple plasma biomarkers as risk factors for coronary artery disease and death in an angiography cohort.CMAJ 2006;174:61-6.
  • 5[5]Ge J,Chirrilio F,Schwedtmann J,et al.Screening of ruptured plaques in patients with coronary artery disease by intravascular ultrasound.Heart 1999;81:21-7.
  • 6[6]Imoto K,,Hiro T,Fujii T,et al.Longitudinal structural determinants of atherosclerotic plaque vulnerability:a computational analysis of stress distribution using vessel models and three-dimensional intravascular ultrasound imaging J Am Coll Cardiol 2005;46:1507-15.
  • 7[7]Vidal-Vanaclocha F,Fantuzzi G,Mendoza L,et al.IL-18 regulates IL-1beta-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1.Pore Ntl Acad Aci U S A 2000;97:734-9.
  • 8[8]Nakanishi K,Yoshimoto T,Tsutsui H,et al.Interleukin-18 regulates both Th1 and Th2 responses.Anna Rev Immunol 2001;19:423-74.
  • 9[9]de Nooijer R,vonder Thusen J,Verkleij C,et al.Overexpression of IL-18 decreases intimal collagen content and promotes a vulnerable plaque phenotype in apolipoprotein-E-deficient mice.Arterioscler Thromb Vase Biol 2004;24:2313-19.
  • 10[10]Christopher MK.The Vulnerable atherosclerotic plaque:strategies for diagnosis and management.Circulation 2007;115:2-3.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部